Nintedanib
|
- $5 - $1490
- Product name: Nintedanib
- CAS: 656247-17-5
- MF: C31H33N5O4
- MW: 539.64
- EINECS:1592732-453-0
- MDL Number:MFCD11974012
- Synonyms:Nintedanib/Intedanib/Vargatef;BIBF 1120; VARGATEF; INTEDANIB;INTEDANIB BASE;Intedanib Vargatef;Nintedanib, Free Base, >99%;methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylate;NTEDANIB;(3Z)-2,3-dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-Indole-6-carboxylic acid methyl ester;methyl (Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylate
102 prices
Selected condition:
Brand
- aablocks
- AccelPharmtech
- ACHEMBLOCK
- Adipogen Life Sciences
- AK Scientific
- Ambeed
- ApexBio Technology
- Arctom
- AvaChem
- Axon Medchem
- Biorbyt Ltd
- Biosynth
- Cayman Chemical
- Chemenu
- ChemScene
- Crysdot
- DC Chemicals
- Matrix Scientific
- TCI Chemical
- Tocris
- TRC
Package
- 10
- 1unit
- 10mg
- 50mg
- 5mg
- 20mg
- 25mg
- 10mM*1mLinDMSO
- 100mg
- 200mg
- 250mg
- 500mg
- 1g
- 2g
- 5g
- 10g
- 25g
- 50G
- EvaluationSample
- 100g
- 10mM(in1mLDMSO)
- 10mM(in 1mL DMSO)
- Manufactureraablocks
- Product numberAA00FBWQ
- Product descriptionMethyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98%
- Packaging50mg
- Price$5
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00FBWQ
- Product descriptionMethyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98%
- Packaging100mg
- Price$7
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00FBWQ
- Product descriptionMethyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98%
- Packaging250mg
- Price$11
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00FBWQ
- Product descriptionMethyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98%
- Packaging1g
- Price$24
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00FBWQ
- Product descriptionMethyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98%
- Packaging5g
- Price$77
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00FBWQ
- Product descriptionMethyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98%
- Packaging10g
- Price$135
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00FBWQ
- Product descriptionMethyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98%
- Packaging25g
- Price$315
- Updated2026-05-28
- Buy
- ManufacturerAccelPharmtech
- Product numberYL1327
- Product descriptionNintedanib 98%+
- Packaging10G
- Price$430
- Updated2021-12-16
- Buy
- ManufacturerAccelPharmtech
- Product numberYL1327
- Product descriptionNintedanib 98%+
- Packaging10G
- Price$430
- Updated2026-05-21
- Buy
- ManufacturerAccelPharmtech
- Product numberYL1327
- Product descriptionNintedanib 98%+
- Packaging25G
- Price$780
- Updated2021-12-16
- Buy
- ManufacturerAccelPharmtech
- Product numberYL1327
- Product descriptionNintedanib 98%+
- Packaging25G
- Price$780
- Updated2026-05-21
- Buy
- ManufacturerAccelPharmtech
- Product numberYL1327
- Product descriptionNintedanib 98%+
- Packaging50G
- Price$1490
- Updated2021-12-16
- Buy
- ManufacturerAccelPharmtech
- Product numberYL1327
- Product descriptionNintedanib 98%+
- Packaging50G
- Price$1490
- Updated2026-05-21
- Buy
- ManufacturerACHEMBLOCK
- Product numberI-9753
- Product descriptionBIBF-1120 98%
- Packaging25G
- Price$330
- Updated2026-05-27
- Buy
- ManufacturerACHEMBLOCK
- Product numberI-9753
- Product descriptionBIBF-1120 98%
- Packaging5G
- Price$110
- Updated2026-05-27
- Buy
- ManufacturerACHEMBLOCK
- Product numberI-9753
- Product descriptionBIBF-1120 98%
- Packaging1G
- Price$35
- Updated2026-05-27
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA00FBWQ | Methyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98% | 50mg | $5 | 2026-05-28 | Buy |
| aablocks | AA00FBWQ | Methyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98% | 100mg | $7 | 2026-05-28 | Buy |
| aablocks | AA00FBWQ | Methyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98% | 250mg | $11 | 2026-05-28 | Buy |
| aablocks | AA00FBWQ | Methyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98% | 1g | $24 | 2026-05-28 | Buy |
| aablocks | AA00FBWQ | Methyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98% | 5g | $77 | 2026-05-28 | Buy |
| aablocks | AA00FBWQ | Methyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98% | 10g | $135 | 2026-05-28 | Buy |
| aablocks | AA00FBWQ | Methyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate 98% | 25g | $315 | 2026-05-28 | Buy |
| AccelPharmtech | YL1327 | Nintedanib 98%+ | 10G | $430 | 2021-12-16 | Buy |
| AccelPharmtech | YL1327 | Nintedanib 98%+ | 10G | $430 | 2026-05-21 | Buy |
| AccelPharmtech | YL1327 | Nintedanib 98%+ | 25G | $780 | 2021-12-16 | Buy |
| AccelPharmtech | YL1327 | Nintedanib 98%+ | 25G | $780 | 2026-05-21 | Buy |
| AccelPharmtech | YL1327 | Nintedanib 98%+ | 50G | $1490 | 2021-12-16 | Buy |
| AccelPharmtech | YL1327 | Nintedanib 98%+ | 50G | $1490 | 2026-05-21 | Buy |
| ACHEMBLOCK | I-9753 | BIBF-1120 98% | 25G | $330 | 2026-05-27 | Buy |
| ACHEMBLOCK | I-9753 | BIBF-1120 98% | 5G | $110 | 2026-05-27 | Buy |
| ACHEMBLOCK | I-9753 | BIBF-1120 98% | 1G | $35 | 2026-05-27 | Buy |
Properties
Melting point :>237oC (dec.)
Boiling point :742.2±60.0 °C(Predicted)
Density :1.284±0.06 g/cm3(Predicted)
storage temp. :Refrigerator
solubility :DMSO (Slightly), Methanol (Slightly)
form :Yellow solid.
pka :11.06±0.20(Predicted)
color :Light Yellow to Light Green
InChIKey :XZXHXSATPCNXJR-ZIADKAODSA-N
SMILES :C(/C1C=CC=CC=1)(=C1\C(NC2=CC(C(=O)OC)=CC=C\12)=O)\NC1C=CC(N(C)C(=O)CN2CCN(C)CC2)=CC=1
Boiling point :742.2±60.0 °C(Predicted)
Density :1.284±0.06 g/cm3(Predicted)
storage temp. :Refrigerator
solubility :DMSO (Slightly), Methanol (Slightly)
form :Yellow solid.
pka :11.06±0.20(Predicted)
color :Light Yellow to Light Green
InChIKey :XZXHXSATPCNXJR-ZIADKAODSA-N
SMILES :C(/C1C=CC=CC=1)(=C1\C(NC2=CC(C(=O)OC)=CC=C\12)=O)\NC1C=CC(N(C)C(=O)CN2CCN(C)CC2)=CC=1
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|
Description
Nintedanib is an oral administrated triple tyrosine kinase inhibitors developed by Boehringer Ingelheim, Germany. Its targets include platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and basic fiber (BFGF), being able to also inhibit the activation of MAPK and Akt. At present, it is mainly used for cancer treatment, such as colorectal cancer, ovarian cancer and multiple myeloma. The study regarding to the respiratory diseases mainly focuses on the clinical treatment of advanced non-small cell lung cancer (NSCLC) and idiopathic pulmonary fibrosis (IPF). In June 2014, Boehringer Ingelheim has announced that the marketing authorization application of Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis (IPF) had been confirmed by the European Medicines Agency (EMA) and been included in the accelerated approval list by the EMA.More related product prices
918505-84-7 BIBF 1202 872511-34-7 Crizotinib Ibrutinib Sunitinib Malate 871700-17-3 Neratinib 1256580-46-7 EAI-045 Olaparib Nintedanib Ethanesulfonate Salt 1,3-DiMethyl 2-[4-(Methoxycarbonyl)-2-nitrophenyl]propanedioate ALPHA,ALPHA,2,4-TETRACHLOROTOLUENE N-Methyl-4-nitroaniline Methyl oxindole-5-carboxylate Methyl 2-oxindole-4-carboxylate 4'-Amino-N-methylacetanilide 14192-26-8 2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLIC ACIDRelated product price
-
918505-84-7
$9-1133.9 -
BIBF 1202
$40-2200 -
872511-34-7
$12-5344
Suppliers and manufacturers
HangZhou RunYan Pharma Technology Co.,LTD.
Nintedanib
CAS:656247-17-5
Hebei Yanxi Chemical Co., Ltd.
Nintedanib
CAS:656247-17-5
shandong perfect biotechnology co.ltd
Nintedanib (BIBF 1120)
CAS:656247-17-5
Hangzhou ICH Biofarm Co., Ltd
Nintedanib (BIBF 1120)
CAS:656247-17-5
Hangzhou Hyper Chemicals Limited
Intedanib
CAS:656247-17-5
Wuhan JiyunZen Tech Co., Ltd.
Nintedanib
CAS:656247-17-5
Hefei Lbao Physical & Chemical Science Co.,Ltd
SyncoZymes (Shanghai) Co., Ltd.,
Wuhan Topule Biopharmaceutical Co., Ltd
Capot Chemical Co.,Ltd.
Nintedanib
CAS:656247-17-5




